CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
34.03 0.23(0.68%) NAV as on 22 Jun 2026
1.55 % 1 M
13.81 % 1 Y
22.81 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.30

As on 31 Mar, 2026
age-icon Age :

6 yrs 11 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

950.31 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.16

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 3.17 %
Equity 96.83 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.42 %
Apollo Hospitals Enterprise Ltd.7.31 %
Torrent Pharmaceuticals Ltd.4.75 %
JB Chemicals & Pharmaceuticals...4.73 %
Aurobindo Pharma Ltd.4.37 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.07
Hospital & Healthcare Services20.09
Business Support1.01
Chemicals0.65
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)18.2216.3626.4529.3930.19
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.33 428.44 699.55 814.95 858.87
Scheme Returns(%)(Absolute)12.40-10.2661.3810.034.21
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity34.030.23(0.68%)NAV As on 22 Jun, 202610-Jul-2019Inception Date950.31AUM In Cr.13.81%1Y22.81%3Y13.12%5Y19.25%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity42.260.50(1.20%)NAV As on 22 Jun, 202613-Jul-2018Inception Date6,453.52AUM In Cr.9.51%1Y26.06%3Y15.95%5Y19.88%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity480.573.94(0.83%)NAV As on 22 Jun, 202614-Jul-1999Inception Date4,565.95AUM In Cr.15.06%1Y23.83%3Y16.38%5Y16.15%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.740.20(0.47%)NAV As on 22 Jun, 202602-Jul-2018Inception Date3,090.51AUM In Cr.14.91%1Y23.68%3Y14.51%5Y19.97%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.980.24(0.75%)NAV As on 22 Jun, 202628-Dec-2015Inception Date1,386.99AUM In Cr.8.51%1Y21.67%3Y13.79%5Y11.72%Since Inception